mmrv vaccine combines attenuated virus mmr measles mumps rubella vaccine addition chickenpox vaccine varicella vaccine v stands varicella mmrv vaccine typically given children one two years age several companies supply mmrv vaccines proquad marketed merck approved use united states food drug administration fda children ages twelve months twelve years mmrv vaccine called priorix glaxosmithkline approved germany world health organization recommends vaccinating measles mumps rubella german measles varicella chickenpox risks diseases far outweigh risks vaccinating particular world health organization recommends varicella vaccination countries vaccine affordable disease relatively important problem high sustained vaccine coverage achieved countries widely implemented mmr varicella vaccine given roughly time booster injection recommended bothcitation needed mmrv vaccine combined mmr varicella vaccine simplifies administration one study indicated rate febrile seizures per vaccinations mmrv opposed per separate mmr varicella shots us health officials known acip therefore express preference use mmrv vaccine separate doctors advised aware whether patient hivaids another disease affects immune system taking medication affects immune system cancer fever active untreated tuberculosis receiving cancer treatment ever low platelet count blood disordercitation needed rare serious adverse events reported following proquad vaccination include allergic reactions including swelling lips tongue face difficulty breathing closing throat hives paleness weakness dizziness fast heart beat deafness longterm seizures coma lowered consciousness seizures jerking staring caused fever temporary low platelet children age two younger mmrv vaccine associated significantly adverse events compared separate administration mmr varicella vaccinations additional febrile seizures per vaccinated children ci additional mostly mild fever episodes per vaccinated children ci additional measleslike rash per children ci febrile seizures caused mmrv vaccine occur days vaccination children age evidence increased risk febrile seizures administration merck proquad compared separate administration mmr varicella merck proquad approved medical use united states september european union april australia february gsk priorix tetra approved medical use australia november httpsenwikipediaorgwikimmrvvaccine